Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster
Clinical trial NCT05465902 · WITHDRAWN
Trial details
- NCT number
- NCT05465902
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2024-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.